JM

Jennifer Meyer

North America, California, United States, Pacific Palisades

Description

Jennifer Meyer continue to build community and collaboration in the business by using their creative ability to support fellow artists.

Investor Profile

Jennifer Meyer has made 1 investments, with 0 in the past 12 months and 0% as lead.

Stage Focus

  • Series A (100%)

Country Focus

  • United States (100%)

Industry Focus

  • Manufacturing
  • Medical
  • Pharmaceutical
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Jennifer Meyer frequently co-invest with?

Verlinvest
Europe, Brussels Hoofdstedelijk Gewest, Belgium, Brussels
Co-Investments: 1
Unilever Ventures
Europe, England, United Kingdom, London
Co-Investments: 1
BC
North America, California, United States, Santa Monica
Co-Investments: 1
Point King Capital
Oceania, New South Wales, Australia, Sydney
Co-Investments: 1
North Castle Partners
North America, Connecticut, United States, Greenwich
Co-Investments: 1
Bill Silva Ventures
North America, California, United States, West Hollywood
Co-Investments: 1

Which angels does Jennifer Meyer often collaborate with?

AM
Europe, Berlin, Germany, Berlin
Shared Deals: 1
DC
North America, Michigan, United States, Metropolitan
Shared Deals: 1
DC
Europe, England, United Kingdom, London
Shared Deals: 1
AF
Europe, England, United Kingdom, London
Shared Deals: 1
DG
North America, New York, United States, New York
Shared Deals: 1
KS
North America, New York, United States, New York
Shared Deals: 1
GP
North America, California, United States
Shared Deals: 1
JS
North America, California, United States, Los Angeles
Shared Deals: 1
BS
North America, California, United States, Los Angeles
Shared Deals: 1
Chris Pattas
Oceania, Victoria, Australia, Melbourne
Shared Deals: 1

What are some of recent deals done by Jennifer Meyer?

Genexa

Atlanta, Georgia, United States

Genexa is a clean medicine company that researches and develops medicine.

ManufacturingMedicalPharmaceutical
Series AJul 14, 2021
Amount Raised: $60,000,000